These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 11040937

  • 1. Molecular pathogenesis of oral squamous carcinoma.
    Williams HK.
    Mol Pathol; 2000 Aug; 53(4):165-72. PubMed ID: 11040937
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Genetic and molecular alterations associated with oral squamous cell cancer (Review).
    Pérez-Sayáns M, Somoza-Martín JM, Barros-Angueira F, Reboiras-López MD, Gándara Rey JM, García-García A.
    Oncol Rep; 2009 Dec; 22(6):1277-82. PubMed ID: 19885577
    [Abstract] [Full Text] [Related]

  • 4. Review article: The role of oncogenes, tumour suppressor genes and growth factors in oral squamous cell carcinoma: a case of apoptosis versus proliferation.
    Sugerman PB, Joseph BK, Savage NW.
    Oral Dis; 1995 Sep; 1(3):172-88. PubMed ID: 8705824
    [Abstract] [Full Text] [Related]

  • 5. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy.
    Choi S, Myers JN.
    J Dent Res; 2008 Jan; 87(1):14-32. PubMed ID: 18096889
    [Abstract] [Full Text] [Related]

  • 6. The molecular biology of oral carcinogenesis: toward a tumor progression model.
    Todd R, Donoff RB, Wong DT.
    J Oral Maxillofac Surg; 1997 Jun; 55(6):613-23; discussion 623-5. PubMed ID: 9191644
    [Abstract] [Full Text] [Related]

  • 7. Oral squamous cell carcinoma: new insights.
    Jordan RC, Daley T.
    J Can Dent Assoc; 1997 Jun; 63(7):517-8, 521-5. PubMed ID: 9264211
    [Abstract] [Full Text] [Related]

  • 8. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma.
    Ha PK, Califano JA.
    Lancet Oncol; 2006 Jan; 7(1):77-82. PubMed ID: 16389187
    [Abstract] [Full Text] [Related]

  • 9. The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma.
    Field JK.
    J R Soc Med; 1995 Jan; 88(1):35P-39P. PubMed ID: 7884768
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z, Hao XY, Liu FX.
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [Abstract] [Full Text] [Related]

  • 12. Molecular aspects of oral cancer.
    Nagler RM.
    Anticancer Res; 2002 May; 22(5):2977-80. PubMed ID: 12530028
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor receptor (EGFR) in oral squamous cell carcinomas: overexpression, localization and therapeutic implications.
    Kuttan NA, Bhakthan NM.
    Indian J Dent Res; 1997 May; 8(1):9-18. PubMed ID: 9495132
    [Abstract] [Full Text] [Related]

  • 14. The hamster model of sequential oral oncogenesis.
    Vairaktaris E, Spyridonidou S, Papakosta V, Vylliotis A, Lazaris A, Perrea D, Yapijakis C, Patsouris E.
    Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
    [Abstract] [Full Text] [Related]

  • 15. Current trends in miRNAs and their relationship with oral squamous cell carcinoma.
    Pérez-Sayáns M, Pilar GD, Barros-Angueira F, Suárez-Peñaranda JM, Fernández AC, Gándara-Rey JM, García-García A.
    J Oral Pathol Med; 2012 Jul; 41(6):433-43. PubMed ID: 22188431
    [Abstract] [Full Text] [Related]

  • 16. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH, Dabelsteen E, Specht L, Fiehn AM, Therkildsen MH, Jønson L, Vikesaa J, Nielsen FC, von Buchwald C.
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [Abstract] [Full Text] [Related]

  • 17. Molecular biology of oral cavity squamous cell carcinoma.
    Kupferman ME, Myers JN.
    Otolaryngol Clin North Am; 2006 Apr; 39(2):229-47. PubMed ID: 16580909
    [Abstract] [Full Text] [Related]

  • 18. [P53 expression and clinical significance in oral squamous cell carcinoma].
    Long Y, Ling D, Yue W.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024
    [Abstract] [Full Text] [Related]

  • 19. Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis.
    Sartini D, Lo Muzio L, Morganti S, Pozzi V, Di Ruscio G, Rocchetti R, Rubini C, Santarelli A, Emanuelli M.
    Oral Dis; 2015 May; 21(4):462-9. PubMed ID: 25439053
    [Abstract] [Full Text] [Related]

  • 20. Aberrant expression of the tight junction molecules claudin-1 and zonula occludens-1 mediates cell growth and invasion in oral squamous cell carcinoma.
    Babkair H, Yamazaki M, Uddin MS, Maruyama S, Abé T, Essa A, Sumita Y, Ahsan MS, Swelam W, Cheng J, Saku T.
    Hum Pathol; 2016 Nov; 57():51-60. PubMed ID: 27436828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.